Clinical Trial Update: Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II [Phase 2]

View source ↗

Summary

Phase II clinical trial update for Vvax001 cancer vaccine in premalignant cervical lesions (CIN3/Cervical Intraepithelial Neoplasia).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia
• Cin3
• Hpv 16 Infection

Drugs mentioned

• Vvax001

Snippet

Sponsor: University Medical Center Groningen | Conditions: CIN3, Cervical Intraepithelial Neoplasia | Phase 2 | Status: UNKNOWN